MARIAH MESSINA: Open Payments
NPI 1285272740 · RIVERHEAD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$902 in 49 payments from 11 companies in 2025. Trend: 2023 $983 · 2024 $668 · 2025 $902
Food & beverage: $854Education: $48
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $174 |
| Janssen Biotech, Inc. | 17 | $163 |
| Novartis Pharmaceuticals Corporation | 5 | $139 |
| Incyte Corporation | 2 | $126 |
| Regeneron Healthcare Solutions, Inc. | 4 | $89 |
| Arcutis Biotherapeutics, Inc. | 4 | $65 |
| Lilly USA, LLC | 2 | $51 |
| Amgen Inc. | 2 | $40 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $24 |
| Journey Medical Corporation | 1 | $16 |
Products named: TREMFYA, OPZELURA, RINVOQ, COSENTYX, SKYRIZI, Zoryve, DUPIXENT, Rhapsido.
Industry payments across NY — which companies pay providers there.
